Perritt Capital Management Inc. Increases Stake in CynergisTek, Inc. (CTEK)

Perritt Capital Management Inc. lifted its position in CynergisTek, Inc. (NYSEAMERICAN:CTEK) by 22.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 402,235 shares of the company’s stock after purchasing an additional 74,042 shares during the period. Perritt Capital Management Inc. owned about 4.23% of CynergisTek worth $1,629,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Shares of CynergisTek, Inc. (NYSEAMERICAN CTEK) opened at $5.20 on Friday. CynergisTek, Inc. has a 1-year low of $2.70 and a 1-year high of $6.72. The firm has a market cap of $47.03, a P/E ratio of 8.81 and a beta of 0.87.

Several brokerages have weighed in on CTEK. Zacks Investment Research lowered shares of CynergisTek from a “hold” rating to a “sell” rating in a research note on Wednesday, December 13th. Roth Capital started coverage on shares of CynergisTek in a research report on Monday, January 29th. They set a “buy” rating and a $7.20 price target on the stock.

COPYRIGHT VIOLATION NOTICE: “Perritt Capital Management Inc. Increases Stake in CynergisTek, Inc. (CTEK)” was originally reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at

CynergisTek Profile

Cynergistek, Inc provides outsourced document management services and IT security consulting services primarily to the healthcare industry in the United States. It offers workflow solutions; and creates manageable, dependable print management programs by managing the back-office processes of hospital clients.

Receive News & Ratings for CynergisTek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CynergisTek and related companies with's FREE daily email newsletter.

Leave a Reply